Singapore, Singapore

Yanbing Zu

This inventor holds 4 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Agency for Science, Technology and Research. Active years: 2018-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yanbing Zu. Retrieved from https://idiyas.com/inventor/yanbing-zu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Yanbing Zu: Innovator in Nucleic Acid Methylation and Genetic Variant Detection

Introduction

Yanbing Zu is a prominent inventor based in Singapore, known for his significant contributions to the field of molecular biology. He holds a total of four patents that focus on innovative methods for determining nucleic acid methylation and detecting genetic variants associated with diseases. His work has implications for both research and clinical applications.

Latest Patents

One of Yanbing Zu's latest patents is titled "Determination of Nucleic Acid Methylation." This invention relates to methods and kits for determining the methylation status of a target nucleic acid molecule in a sample. The process involves several steps, including bisulfite treatment of the target nucleic acid, amplification with methylation-specific primers, and the use of a methylation-specific plasmonic nanoprobe. The methylation status is determined based on the melting temperature of the hybrid probe and the target nucleic acid. Notably, this patent also includes methods and kits for determining the methylation status of the Septin 9 (SEPT9) gene promoter.

Another significant patent is the "Method for Detection of a Genetic Variant." This invention provides a method and kit for detecting a genetic variant associated with a disease or disorder, including potential incompatibility with pharmaceuticals. The method utilizes a first nanoparticle coupled to at least one morpholino nucleic acid probe that has a target complementary region base sequence perfectly matching the genetic variant sequence.

Career Highlights

Yanbing Zu is affiliated with the Agency for Science, Technology and Research, where he continues to advance his research in molecular biology. His innovative approaches have garnered attention in the scientific community, contributing to the understanding of genetic variations and their implications in health.

Collaborations

Throughout his career, Yanbing Zu has collaborated with notable scientists, including Jackie Yi-Ru Ying and Jackie Y Ying. These collaborations have further enriched his research and expanded the impact of his inventions.

Conclusion

Yanbing Zu is a distinguished inventor whose work in nucleic acid methylation and genetic variant detection is paving the way for advancements in molecular biology. His patents reflect a commitment to innovation and a desire to improve diagnostic methods in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…